Genky DrugStores Co., Ltd. (TYO:9267)
2,950.00
+28.00 (0.96%)
Mar 14, 2025, 3:30 PM JST
Genky DrugStores Balance Sheet
Financials in millions JPY. Fiscal year is July - June.
Millions JPY. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 20, 2024 | Jun '24 Jun 20, 2024 | Jun '23 Jun 20, 2023 | Jun '22 Jun 20, 2022 | Jun '21 Jun 20, 2021 | Jun '20 Jun 20, 2020 | 2019 - 2015 |
Cash & Equivalents | 6,943 | 5,896 | 5,329 | 5,438 | 7,913 | 6,620 | Upgrade
|
Cash & Short-Term Investments | 6,943 | 5,896 | 5,329 | 5,438 | 7,913 | 6,620 | Upgrade
|
Cash Growth | 70.84% | 10.64% | -2.00% | -31.28% | 19.53% | 170.98% | Upgrade
|
Accounts Receivable | 3,938 | 4,685 | 3,925 | 2,799 | 2,601 | 2,292 | Upgrade
|
Other Receivables | - | 2,406 | 2,259 | 2,014 | 1,816 | 1,461 | Upgrade
|
Receivables | 3,938 | 7,091 | 6,184 | 4,813 | 4,417 | 3,753 | Upgrade
|
Inventory | 26,744 | 24,028 | 22,490 | 20,911 | 19,389 | 18,287 | Upgrade
|
Other Current Assets | 3,109 | 319 | 410 | 352 | 421 | 623 | Upgrade
|
Total Current Assets | 40,734 | 37,334 | 34,413 | 31,514 | 32,140 | 29,283 | Upgrade
|
Property, Plant & Equipment | 72,638 | 69,936 | 65,104 | 59,260 | 52,527 | 47,839 | Upgrade
|
Long-Term Investments | 6,201 | 3,760 | 3,637 | 3,680 | 3,569 | 3,358 | Upgrade
|
Other Intangible Assets | 341 | 378 | 363 | 374 | 394 | 303 | Upgrade
|
Long-Term Deferred Tax Assets | - | 2,039 | 1,840 | 1,698 | 1,578 | 1,578 | Upgrade
|
Other Long-Term Assets | 2 | 2 | 1 | 1 | 1 | 2 | Upgrade
|
Total Assets | 119,916 | 113,939 | 105,912 | 97,118 | 90,795 | 83,145 | Upgrade
|
Accounts Payable | 26,019 | 24,188 | 22,192 | 20,564 | 19,616 | 17,262 | Upgrade
|
Accrued Expenses | 106 | 133 | 136 | 105 | 128 | 106 | Upgrade
|
Current Portion of Long-Term Debt | 7,914 | 8,088 | 11,242 | 10,180 | 6,816 | 5,919 | Upgrade
|
Current Portion of Leases | - | 7 | 19 | 17 | 30 | 52 | Upgrade
|
Current Income Taxes Payable | 1,633 | 6,939 | 5,467 | 5,594 | 6,330 | 4,822 | Upgrade
|
Other Current Liabilities | 5,390 | 1,491 | 1,060 | 1,187 | 1,721 | 803 | Upgrade
|
Total Current Liabilities | 41,062 | 40,846 | 40,116 | 37,647 | 34,641 | 28,964 | Upgrade
|
Long-Term Debt | 24,988 | 22,408 | 20,946 | 20,754 | 21,684 | 24,113 | Upgrade
|
Long-Term Leases | - | 145 | 147 | 8 | 25 | 307 | Upgrade
|
Other Long-Term Liabilities | 4,074 | 3,861 | 4,023 | 2,477 | 2,281 | 2,077 | Upgrade
|
Total Liabilities | 70,124 | 67,260 | 65,232 | 60,886 | 58,631 | 55,461 | Upgrade
|
Common Stock | 1,035 | 1,024 | 1,010 | 1,008 | 1,000 | 1,000 | Upgrade
|
Additional Paid-In Capital | 6,451 | 6,440 | 6,426 | 6,424 | 6,415 | 6,795 | Upgrade
|
Retained Earnings | 42,933 | 39,862 | 33,917 | 29,531 | 25,479 | 20,647 | Upgrade
|
Treasury Stock | -790 | -790 | -789 | -789 | -789 | -788 | Upgrade
|
Comprehensive Income & Other | 163 | 143 | 116 | 58 | 59 | 30 | Upgrade
|
Shareholders' Equity | 49,792 | 46,679 | 40,680 | 36,232 | 32,164 | 27,684 | Upgrade
|
Total Liabilities & Equity | 119,916 | 113,939 | 105,912 | 97,118 | 90,795 | 83,145 | Upgrade
|
Total Debt | 32,902 | 30,648 | 32,354 | 30,959 | 28,555 | 30,391 | Upgrade
|
Net Cash (Debt) | -25,959 | -24,752 | -27,025 | -25,521 | -20,642 | -23,771 | Upgrade
|
Net Cash Per Share | -852.84 | -813.77 | -889.27 | -839.63 | -679.35 | -783.11 | Upgrade
|
Filing Date Shares Outstanding | 30.4 | 30.38 | 30.37 | 30.37 | 30.35 | 30.35 | Upgrade
|
Total Common Shares Outstanding | 30.4 | 30.38 | 30.37 | 30.37 | 30.35 | 30.35 | Upgrade
|
Working Capital | -328 | -3,512 | -5,703 | -6,133 | -2,501 | 319 | Upgrade
|
Book Value Per Share | 1638.11 | 1536.31 | 1339.57 | 1193.22 | 1059.62 | 912.02 | Upgrade
|
Tangible Book Value | 49,451 | 46,301 | 40,317 | 35,858 | 31,770 | 27,381 | Upgrade
|
Tangible Book Value Per Share | 1626.89 | 1523.87 | 1327.62 | 1180.90 | 1046.64 | 902.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.